Showing posts with label Upper GI bleed. Non Variceal. Show all posts
Showing posts with label Upper GI bleed. Non Variceal. Show all posts

Monday, February 24, 2020

Upper GI bleed. Non Variceal

Non-variceal upper gastrointestinal bleeding (NVUGIB) is bleeding that develops in the esophagus, stomach or proximal duodenum. 
Peptic ulcers, caused by Helicobacter pylori infection or the use of NSAIDs and low-dose aspirin (LDA), are the most common cause.
Non-variceal upper gastrointestinal bleeding (UGIB) is still accompanied by a significant mortality rate in older patients. 

Causes of UGIB are ulcers, Mallory-Weiss lesions, erosions, esophagitis or angiodysplasia. 


Endoscopy offers the localization of the bleeding site as well as a variety of therapeutic measures. Patients with peptic lesions are effectively treated with proton pump inhibitors. Helicobacter pylori is a risk factor for the genesis of peptic ulcers and eradication therapy should be given if it is present
Initial workup :

·       History of Hemetemesis or Melena /Hematochezia
·       H/O NSAIDS use /Anticoagulants/antiplatelets/steroids /Peptic ulcer
Examination: Hemodynamic status, vitals
Look for Vascular lesions on the skin
Consider variceal if : Splenomegaly /ascites /Features of CLD    

Investigations

·       Hemogram, RFT, LFT INR Sugar, ECG, X-ray chest  
·       USG to rule out CLD
·       Serology: HBsAg, anti-HCV, HIV as pre-procedure Investigation  
·       Plan UGI endoscopy    

  
Management

 Treatment may include the following:
  • Secure the airway
  • Insert bilateral, 16-gauge (minimum), upper extremity, peripheral intravenous lines
  • Arrange Blood /FFP/Platelets depending upon CBC &INR
  • Replace each milliliter of blood loss with 3 mL of crystalloid fluid
  • Foley catheter placement for continuous evaluation of urinary output as a guide to renal perfusion
  • Endoscopic hemostatic therapy for bleeding ulcers if SRH(Spurter,Ooze,Clot,Visible vessel ) seen on Endoscopy 
  • Surgical repair of a perforated viscus
  • For high-risk peptic ulcer patients, high-dose intravenous proton pump inhibitors: 80MG IV bolus followed by 20-40mg IV 6hrly for 3days or Till endoscopy  followed by 20-40mg  IV BD for  Ia/Ib/IIa/IIb and oral for IIC/III lesions 
  • Indications for surgery in patients with bleeding peptic ulcers include the following:
  • Severe, life-threatening hemorrhage not responsive to resuscitative efforts
  • Failure of medical therapy and endoscopic hemostasis with persistent recurrent bleeding
  • A coexisting reason for surgery (eg, perforation, obstruction, malignancy)
  • Prolonged bleeding, with loss of 50% or more of the patient's blood volume
  • A second hospitalization for peptic ulcer hemorrhage